226 related articles for article (PubMed ID: 28266655)
1. Intact sensory-motor network structure and function in far from onset premanifest Huntington's disease.
Gorges M; Müller HP; Mayer IM; Grupe GS; Kammer T; Grön G; Kassubek J; Landwehrmeyer GB; Wolf RC; Orth M
Sci Rep; 2017 Mar; 7():43841. PubMed ID: 28266655
[TBL] [Abstract][Full Text] [Related]
2. Motor network structure and function are associated with motor performance in Huntington's disease.
Müller HP; Gorges M; Grön G; Kassubek J; Landwehrmeyer GB; Süßmuth SD; Wolf RC; Orth M
J Neurol; 2016 Mar; 263(3):539-49. PubMed ID: 26762394
[TBL] [Abstract][Full Text] [Related]
3. Natural variation in sensory-motor white matter organization influences manifestations of Huntington's disease.
Orth M; Gregory S; Scahill RI; Mayer IS; Minkova L; Klöppel S; Seunarine KK; Boyd L; Borowsky B; Reilmann R; Bernhard Landwehrmeyer G; Leavitt BR; Roos RA; Durr A; Rees G; Rothwell JC; Langbehn D; Tabrizi SJ;
Hum Brain Mapp; 2016 Dec; 37(12):4615-4628. PubMed ID: 27477323
[TBL] [Abstract][Full Text] [Related]
4. Longitudinal changes in functional connectivity of cortico-basal ganglia networks in manifests and premanifest huntington's disease.
Gargouri F; Messé A; Perlbarg V; Valabregue R; McColgan P; Yahia-Cherif L; Fernandez-Vidal S; Ben Hamida A; Benali H; Tabrizi S; Durr A; Lehéricy S
Hum Brain Mapp; 2016 Nov; 37(11):4112-4128. PubMed ID: 27400836
[TBL] [Abstract][Full Text] [Related]
5. Timing of selective basal ganglia white matter loss in premanifest Huntington's disease.
Zeun P; McColgan P; Dhollander T; Gregory S; Johnson EB; Papoutsi M; Nair A; Scahill RI; Rees G; Tabrizi SJ;
Neuroimage Clin; 2022; 33():102927. PubMed ID: 34999565
[TBL] [Abstract][Full Text] [Related]
6. Biological and clinical characteristics of gene carriers far from predicted onset in the Huntington's disease Young Adult Study (HD-YAS): a cross-sectional analysis.
Scahill RI; Zeun P; Osborne-Crowley K; Johnson EB; Gregory S; Parker C; Lowe J; Nair A; O'Callaghan C; Langley C; Papoutsi M; McColgan P; Estevez-Fraga C; Fayer K; Wellington H; Rodrigues FB; Byrne LM; Heselgrave A; Hyare H; Sampaio C; Zetterberg H; Zhang H; Wild EJ; Rees G; Robbins TW; Sahakian BJ; Langbehn D; Tabrizi SJ
Lancet Neurol; 2020 Jun; 19(6):502-512. PubMed ID: 32470422
[TBL] [Abstract][Full Text] [Related]
7. Cortical thickness, stance control, and arithmetic skill: An exploratory study in premanifest Huntington disease.
Nanetti L; Contarino VE; Castaldo A; Sarro L; Bachoud-Levi AC; Giavazzi M; Frittoli S; Ciammola A; Rizzo E; Gellera C; Bruzzone MG; Taroni F; Grisoli M; Mariotti C
Parkinsonism Relat Disord; 2018 Jun; 51():17-23. PubMed ID: 29496355
[TBL] [Abstract][Full Text] [Related]
8. Brain activation and functional connectivity in premanifest Huntington's disease during states of intrinsic and phasic alertness.
Wolf RC; Grön G; Sambataro F; Vasic N; Wolf ND; Thomann PA; Saft C; Landwehrmeyer GB; Orth M
Hum Brain Mapp; 2012 Sep; 33(9):2161-73. PubMed ID: 22887827
[TBL] [Abstract][Full Text] [Related]
9. Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: analysis of 36-month observational data.
Tabrizi SJ; Scahill RI; Owen G; Durr A; Leavitt BR; Roos RA; Borowsky B; Landwehrmeyer B; Frost C; Johnson H; Craufurd D; Reilmann R; Stout JC; Langbehn DR;
Lancet Neurol; 2013 Jul; 12(7):637-49. PubMed ID: 23664844
[TBL] [Abstract][Full Text] [Related]
10. Microstructural brain abnormalities in Huntington's disease: A two-year follow-up.
Odish OF; Leemans A; Reijntjes RH; van den Bogaard SJ; Dumas EM; Wolterbeek R; Tax CM; Kuijf HJ; Vincken KL; van der Grond J; Roos RA
Hum Brain Mapp; 2015 Jun; 36(6):2061-74. PubMed ID: 25644819
[TBL] [Abstract][Full Text] [Related]
11. Striatal hypometabolism in premanifest and manifest Huntington's disease patients.
López-Mora DA; Camacho V; Pérez-Pérez J; Martínez-Horta S; Fernández A; Sampedro F; Montes A; Lozano-Martínez GA; Gómez-Anson B; Kulisevsky J; Carrió I
Eur J Nucl Med Mol Imaging; 2016 Nov; 43(12):2183-2189. PubMed ID: 27349245
[TBL] [Abstract][Full Text] [Related]
12. Longitudinal resting state fMRI analysis in healthy controls and premanifest Huntington's disease gene carriers: a three-year follow-up study.
Odish OF; van den Berg-Huysmans AA; van den Bogaard SJ; Dumas EM; Hart EP; Rombouts SA; van der Grond J; Roos RA;
Hum Brain Mapp; 2015 Jan; 36(1):110-9. PubMed ID: 25139578
[TBL] [Abstract][Full Text] [Related]
13. Biological and clinical changes in premanifest and early stage Huntington's disease in the TRACK-HD study: the 12-month longitudinal analysis.
Tabrizi SJ; Scahill RI; Durr A; Roos RA; Leavitt BR; Jones R; Landwehrmeyer GB; Fox NC; Johnson H; Hicks SL; Kennard C; Craufurd D; Frost C; Langbehn DR; Reilmann R; Stout JC;
Lancet Neurol; 2011 Jan; 10(1):31-42. PubMed ID: 21130037
[TBL] [Abstract][Full Text] [Related]
14. Mapping the order and pattern of brain structural MRI changes using change-point analysis in premanifest Huntington's disease.
Wu D; Faria AV; Younes L; Mori S; Brown T; Johnson H; Paulsen JS; Ross CA; Miller MI;
Hum Brain Mapp; 2017 Oct; 38(10):5035-5050. PubMed ID: 28657159
[TBL] [Abstract][Full Text] [Related]
15. Altered ventral striatal activation during reward and punishment processing in premanifest Huntington's disease: a functional magnetic resonance study.
Enzi B; Edel MA; Lissek S; Peters S; Hoffmann R; Nicolas V; Tegenthoff M; Juckel G; Saft C
Exp Neurol; 2012 May; 235(1):256-64. PubMed ID: 22366326
[TBL] [Abstract][Full Text] [Related]
16. Progressive microstructural changes of the occipital cortex in Huntington's disease.
Odish OFF; Reijntjes RHAM; van den Bogaard SJA; Roos RAC; Leemans A
Brain Imaging Behav; 2018 Dec; 12(6):1786-1794. PubMed ID: 29492750
[TBL] [Abstract][Full Text] [Related]
17. Natural biological variation of white matter microstructure is accentuated in Huntington's disease.
Gregory S; Crawford H; Seunarine K; Leavitt B; Durr A; Roos RAC; Scahill RI; Tabrizi SJ; Rees G; Langbehn D; Orth M
Hum Brain Mapp; 2018 Sep; 39(9):3516-3527. PubMed ID: 29682858
[TBL] [Abstract][Full Text] [Related]
18. Altered iron and myelin in premanifest Huntington's Disease more than 20 years before clinical onset: Evidence from the cross-sectional HD Young Adult Study.
Johnson EB; Parker CS; Scahill RI; Gregory S; Papoutsi M; Zeun P; Osborne-Crowley K; Lowe J; Nair A; Estevez-Fraga C; Fayer K; Rees G; Zhang H; Tabrizi SJ;
EBioMedicine; 2021 Mar; 65():103266. PubMed ID: 33706250
[TBL] [Abstract][Full Text] [Related]
19. Impaired postural stability as a marker of premanifest Huntington's disease.
Salomonczyk D; Panzera R; Pirogovosky E; Goldstein J; Corey-Bloom J; Simmons R; Gilbert PE
Mov Disord; 2010 Oct; 25(14):2428-33. PubMed ID: 20818666
[TBL] [Abstract][Full Text] [Related]
20. Default-mode network changes in preclinical Huntington's disease.
Wolf RC; Sambataro F; Vasic N; Wolf ND; Thomann PA; Saft C; Landwehrmeyer GB; Orth M
Exp Neurol; 2012 Sep; 237(1):191-8. PubMed ID: 22742947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
